Skip to main content
Log in

Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aim

Hematopoietic cytokines (HCs) regulate the proliferation and differentiation of hematopoietic progenitor cells, and it was proved that HCs can promote cancer growth. The aim of this study is to determine whether HCs might be useful in the diagnosis of colorectal cancer.

Materials and methods

We compared the serum levels of stem cell factor (SCF), interleukin 3 (IL-3), granulocyte–macrophage colony-stimulating factor (GM-CSF), and macrophage colony-stimulating factor (M-CSF) in 97 colorectal cancer patients with those in 35 patients with colorectal adenomas and 65 healthy subjects (control group). Additionally, we investigated commonly accepted tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9). HCs were determined using enzyme linked immunosorbent assay (ELISA). CEA and CA 19-9 were measured by microparticle enzyme immunoassay.

Results

Serum levels of GM-CSF, M-CSF, and tumor markers were significantly higher in cancer patients as compared to the control group and adenomas patients. Of these, hematopoietic cytokines were found elevated in the higher proportion of patients than CEA and CA 19-9. The sensitivity of SCF was higher than the sensitivity of other cytokines, but diagnostic specificity and predictive value were highest for M-CSF. Moreover, the M-CSF area under the receiver operating characteristic curve was larger than the areas of other cytokines. The highest values of diagnostic parameters were observed for the combined use of M-CSF with CEA.

Conclusion

The obtained data support the M-CSF usefulness as a tumor marker for colorectal cancer, especially in combination with CEA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, Wasielewski R (2002) Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123:1478–1484

    Article  PubMed  CAS  Google Scholar 

  2. Lynch JP, Hoops TC (2002) The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 16:775–810

    Article  PubMed  Google Scholar 

  3. Schulmann K (2002) Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 16:91–114

    Article  PubMed  Google Scholar 

  4. Ahmad NA, Kochman ML, Ginsberg GG (2002) Endoscopic ultrasound and endoscopic mucosal resection for rectal cancers and villous adenomas. Hematol Oncol Clin North Am 16:897–906

    Article  PubMed  Google Scholar 

  5. Negm RS, Verma M, Srivastava S (2002) The promise of biomarkers in cancer screening and detection. Trends Mol Med 8:288–293

    Article  PubMed  CAS  Google Scholar 

  6. Smith MA, Court EL, Smith JG (2001) Stem cell factor: laboratory and clinical aspects. Blood Rev 15:191–197

    Article  PubMed  CAS  Google Scholar 

  7. Trutmann M, Terracciano L, Noppen C, Kloth J, Kaspar M, Peterli R, Tondelli P, Schaefer Ch, Zajac P, Heberer M, Spagnoli GC (1998) GM-CSF gene expression and protein production in human colorectal cell lines and clinical tumor specimens. Int J Cancer 77:378–385

    Article  PubMed  CAS  Google Scholar 

  8. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374–380

    PubMed  CAS  Google Scholar 

  9. McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc Ph, Pouillart P, Scholl SM (2002) Circulating macrophage colony stimulating factor as a marker of tumor progression. Eur Cytokine Netw 13:121–127

    PubMed  CAS  Google Scholar 

  10. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N (1999) Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 79:40–46

    Article  PubMed  CAS  Google Scholar 

  11. Mroczko B, Szmitkowski M, Okulczyk B (2003) Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 41:646–651

    Article  PubMed  CAS  Google Scholar 

  12. Mroczko B, Szmitkowski M, Wereszczyñska-Siemiątkowska U, Okulczyk B (2005) Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. Dig Dis Sci 50:1019–1024

    Article  PubMed  CAS  Google Scholar 

  13. Fleming ID, Cooper JS, Henson DE, Hutter VP, Kennedy BJ, Murphy GP, O’Sullivan B, Sobin LH, Yarbro JW (1997) Colon and rectum. AJCC Cancer Staging Manual. Lippincott-Raven, New York

    Google Scholar 

  14. Jass JR, Sobin LH (1989) Definition and explanatory notes. Large intestine. Histological typing of intestinal tumors. Springer, Berlin Heidelberg New York

    Google Scholar 

  15. Fischer LD, Belle G, Biostatistics (1993) A methodology for the health sciences. Wiley, New York

    Google Scholar 

  16. Lindblom A, Liljegren A (2000) Tumour markers in malignancies BMJ 320:424–427

    Article  PubMed  CAS  Google Scholar 

  17. Dunlop RJ, Campbell CW (2000) Cytokines and advanced cancer. J Pain Symptom Manage 20:214–232

    Article  PubMed  CAS  Google Scholar 

  18. Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, Suardet L, Givel JC, Odartchenko N (1995) Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 6:1111–1118

    PubMed  CAS  Google Scholar 

  19. Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer J, Givel JC, Odartchenko N (1994) Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res 54:3700–3702

    PubMed  CAS  Google Scholar 

  20. Calatayud S, Warner TD, Breese EJ, Mitchell JA (2002) Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosis. Cytokine 20:163–167

    Article  PubMed  CAS  Google Scholar 

  21. Rutkowski P, Kamiñska J, Kowalska M, Ruka W, Steffen J (2002) Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer 100:463–471

    Article  PubMed  CAS  Google Scholar 

  22. Kaminska J, Nowacki, MP, Kowalska MM, Rysinska A, Chwalinski M, Fuksiewicz M, Michalski W (2005) Correlation of serum cytokines with clinicopathological features and prognosis in patients with colorectal carcinoma. Soluble sTNF RI an independent prognostic factor. Tumour Biol 26:186–194

    Article  PubMed  CAS  Google Scholar 

  23. Esposito I, Kleeff J, Bischoff SC, Fischer L, Collecchi P, Iorio M, Bevilacqua G, Buchler MW, Friess H (2002) The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 82:1481–1492

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by the State Committee for Scientific Research (KBN) (grant 3 PO5B 02325).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maciej Szmitkowski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mroczko, B., Szmitkowski, M., Wereszczyńska-Siemiątkowska, U. et al. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer. Int J Colorectal Dis 22, 33–38 (2007). https://doi.org/10.1007/s00384-006-0099-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-006-0099-4

Keywords

Navigation